[{"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0302-2017", "product_description": "Testosterone Cypionate in Sesame Oil, 250 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "1,244 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06272016A (12/24/2016), 08242016A (02/20/2017), 09212016B (03/20/2017), 07252016A (01/21/2017), 08112016B (02/07/2017), 10252016L (02/28/2017)."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0359-2015", "product_description": "Linezolid various strengths in dextrose", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0094-2020", "product_description": "Sermorelin Acetate, 3 mg/mL/GHRP6, 1.8 mg/mL/GHRP2, 1.8 mg/mL, 3 mL Injections-CART-Item#: 73752, For SC Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "218 cartridges", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-553", "16714-554", "16714-555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["a11626b3-d7a9-43b0-85d4-38a582acd661"], "spl_set_id": ["e2511ffe-5821-4f64-a469-f8ef9618b1b5"], "package_ndc": ["16714-553-01", "16714-554-01", "16714-555-01"], "is_original_packager": [true], "upc": ["0316714554013", "0316714553016", "0316714555010"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "95660", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0096-2025", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-553-01.", "product_quantity": "5232 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.", "recall_initiation_date": "20241101", "center_classification_date": "20241203", "report_date": "20241211", "code_info": "Lot #: 17222544, Exp 11/30/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0185-2016", "product_description": "BIEST CP 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3)) 1.25 MG capsules, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "240 capsules", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 02182015:78@22, Exp 2/18/2016; Lot # 02182015:98@23, Exp 2/18/2016"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090308"], "brand_name": ["CLOZAPINE"], "generic_name": ["CLOZAPINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5376", "0093-5416", "0093-5417", "0093-5419", "0093-5377"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOZAPINE"], "rxcui": ["476177", "476179", "721773", "996921", "1006801"], "spl_id": ["1b735bc2-6341-40af-8696-e61621d91ee8"], "spl_set_id": ["6fccf4f7-2e30-4272-9800-225aaef20584"], "package_ndc": ["0093-5416-01", "0093-5417-01", "0093-5417-19", "0093-5417-84", "0093-5419-01", "0093-5419-19", "0093-5419-84", "0093-5376-01", "0093-5376-19", "0093-5376-84", "0093-5377-01", "0093-5377-19", "0093-5377-84"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["J60AR2IKIC"]}, "product_type": "Drugs", "event_id": "81068", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide in the USA", "recall_number": "D-0001-2019", "product_description": "Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 0093-5416-01  Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.", "product_quantity": "313 bottles", "reason_for_recall": "Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.", "recall_initiation_date": "20180921", "center_classification_date": "20181001", "termination_date": "20190501", "report_date": "20181010", "code_info": "Lot #: 34034024B, Exp 02/20", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0452-2018", "product_description": "Ketamine HCl Injection in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70914", "recalling_firm": "Romark Laboratories, L.C.", "address_1": "3000 Bayport Dr Ste 200", "address_2": "N/A", "postal_code": "33607-8416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0983-2015", "product_description": "Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607", "product_quantity": "32,893 bottles", "reason_for_recall": "Failed Stability Specifications: Product failed to meet 12 months long term stability specification  for viscosity", "recall_initiation_date": "20150424", "center_classification_date": "20150504", "termination_date": "20161025", "report_date": "20150513", "code_info": "Lot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017."}, {"status": "Terminated", "city": "Cerkezkoy", "state": "N/A", "country": "Turkey", "classification": "Class II", "openfda": {"application_number": ["ANDA207658"], "brand_name": ["TEMOZOLOMIDE"], "generic_name": ["TEMOZOLOMIDE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-537", "67877-538", "67877-539", "67877-540", "67877-541", "67877-542"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TEMOZOLOMIDE"], "rxcui": ["313209", "313210", "313211", "317160", "700883", "700885"], "spl_id": ["f519f4f0-bb62-43cb-bfc2-15f00ac1aad3"], "spl_set_id": ["33d67bce-38ae-45fc-a858-d51167b0ecfd"], "package_ndc": ["67877-537-07", "67877-537-14", "67877-538-07", "67877-538-14", "67877-539-07", "67877-539-14", "67877-540-07", "67877-540-14", "67877-541-07", "67877-541-14", "67877-542-07"], "is_original_packager": [true], "nui": ["N0000000236", "N0000175558"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "unii": ["YF1K15M17Y"]}, "product_type": "Drugs", "event_id": "83327", "recalling_firm": "Deva Holding AS - Cerkezkoy Subesi", "address_1": "Organize Fatih Bulvar Fatih Bulvar 32 Cerkezkoy", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1511-2019", "product_description": "Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.", "product_quantity": "a) 7380 bottles; b) 10332 bottles", "reason_for_recall": "CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.", "recall_initiation_date": "20190716", "center_classification_date": "20190723", "termination_date": "20220106", "report_date": "20190731", "code_info": "Lot #:  a) A063581, A063462, A063460, Exp 09/30/2019;  A063582, Exp 10/31/2019; A069129, Exp 05/31/2020; A071801, Exp 09/30/2020; b) A063639, A063624, A063609, Exp 09/30/2019; A063657, Exp 10/31/2019; A069366, Exp 05/31/2020; A071817, A071819, A071818, Exp 09/30/2020"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76103", "recalling_firm": "VIRTUS PHARMACEUTICALS OPCO II L", "address_1": "1321 Murfreesboro Pike #", "address_2": "N/A", "postal_code": "37217-2726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0241-2017", "product_description": "VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30", "product_quantity": "124,250 bottles", "reason_for_recall": "cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.", "recall_initiation_date": "20161212", "center_classification_date": "20161228", "termination_date": "20180821", "report_date": "20170104", "code_info": "Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017,  21512164 Exp. date 11/30/2017"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71799", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1351-2015", "product_description": "ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).", "product_quantity": "6001 vials", "reason_for_recall": "Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution", "recall_initiation_date": "20150724", "center_classification_date": "20150824", "termination_date": "20161102", "report_date": "20150902", "code_info": "Lot #  31317857B, Exp 08/15  31317859B, Exp 12/15  31317920B, Exp 12/15  31317957B, Exp 12/15  31318136B, Exp 12/15  31318138B, Exp 12/15"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1056-2015", "product_description": "Lansoprazole 3 mg/mL Susp, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0782-2023", "product_description": "Acyclovir Oral Suspension, 200mg/5mL, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"country": "United States", "city": "Libertyville", "address_1": "2401 Commerce Dr", "reason_for_recall": "Labeling: Not elsewhere classified - count on the label was incorrect.", "address_2": "", "product_quantity": "2730 bottles", "code_info": "Lot # 6050129, Exp 05/31/17", "center_classification_date": "20160505", "distribution_pattern": "Virginia", "state": "IL", "product_description": "Acetaminophen & Codeine Phosphate Tablets, 300 mg/30 mg, 15-count plastic bottle, Rx only, Mfr: Aurolife Pharma LLC, Dayton NJ, Packaged Exclusively by: A-S Medication Solutions LLC, Libertyville, ILL 60048, NDC 54569-8305-0", "report_date": "20160511", "classification": "Class III", "openfda": {}, "recalling_firm": "A-S Medication Solutions LLC.", "recall_number": "D-0839-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "74011", "termination_date": "20161020", "more_code_info": "", "recall_initiation_date": "20160422", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-888-2015", "product_description": "Secnidazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "12025 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["CHILDRENS PAIN AND FEVER"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Kroger Company"], "product_ndc": ["30142-818"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["251d2380-9418-4465-99f4-050b723db1ad"], "spl_set_id": ["d965eba0-b268-41b2-8e02-5f6d769a44d7"], "package_ndc": ["30142-818-26"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0586-2022", "product_description": "Acetaminophen Child Dye Free Cherry Flavor Oral Suspension (160mg/5ml), 4 FL OZ (118 mL) per bottle, DISTRIBUTED BY THE KROGER CO. CINCINNATI, OHIO 45202.  NDC: 30142-818-26", "product_quantity": "3,120 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK1045, Exp 12/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078181"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Accord Healthcare Inc"], "product_ndc": ["16729-001", "16729-002", "16729-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["415deb6c-47dc-ed2a-e063-6394a90a66fa"], "spl_set_id": ["9b74fbac-9e04-4927-9981-1e3dace89c6d"], "package_ndc": ["16729-001-01", "16729-001-16", "16729-001-17", "16729-002-01", "16729-002-16", "16729-002-17", "16729-003-01", "16729-003-16", "16729-003-17"], "is_original_packager": [true], "upc": ["0316729003018", "0316729002011", "316729002011", "316729002165"], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0394-2023", "product_description": "Glimepiride Tablets USP, 2 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-002-01 UPC 3 16729 00201 1; b) 500 Tablets NDC 16729-002-16 UPC 3 16729 00216 5; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "992,622 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) R2000184, Exp. Date 4/30/2023, R2000183 Exp. Date 4/30/2023, P2002969 Exp. Date 5/31/2023, P2002970 Exp. Date 5/31/2023, P2005346 Exp. Date 8/31/2023, P2005847 Exp. Date 10/31/2023, P2006133 Exp. Date 10/31/2023, P2100682 Exp. Date 1/31/2024, P2102065 Exp. Date 3/31/2024, P2102067 Exp. Date 3/31/2024, P2102068 Exp. Date 3/31/2024, P2102070 Exp. Date 3/31/2024, R2100659 Exp. Date 5/31/2024, R2100660 Exp. Date 5/31/2024, P2103898 Exp. Date 6/30/2024, P2106000 Exp. Date 7/31/2024, R2101442 Exp. Date 9/30/2024, P2201160 Exp. Date 1/31/2025, P2200695 Exp. Date 1/31/2025, P2200694 Exp. Date 1/31/2025; b) P2005530, Exp. Date 9/30/2023, P2005531 Exp. Date 9/30/2023, P2005532 Exp. Date 9/30/2023, P2005533 Exp. Date 9/30/2023, P2005846 Exp. Date 10/31/2023, P2006594 Exp. Date 11/30/2023, P2100602 Exp. Date 1/31/2024, P2100603 Exp. Date 1/31/2024, P2100604 Exp. Date 1/31/2024, P2100605 Exp. Date 1/31/2024, P2101571 Exp. Date 2/29/2024, P2101572 Exp. Date 2/29/2024, P2102046 Exp. Date 3/31/2024, P2102047 Exp. Date 3/31/2024, P2102049 Exp. Date 3/31/2024, P2102050 Exp. Date 3/31/2024, P2102051 Exp. Date 3/31/2024, P2102052 Exp. Date 3/31/2024, P2103017 Exp. Date 4/30/2024, P2103018 Exp. Date 4/30/2024, P2103900 Exp. Date 6/30/2024, P2104436 Exp. Date 6/30/2024, P2105399 Exp. Date 7/31/2024, P2105400 Exp. Date 7/31/2024, P2106257 Exp. Date 9/30/2024, P2106258 Exp. Date 9/30/2024, P2106259 Exp. Date 9/30/2024, R2101443 Exp. Date 9/30/2024, R2101445 Exp. Date 9/30/2024, R2101444 Exp. Date 9/30/2024, R2200082 Exp. Date 12/31/2024, R2200080 Exp. Date 12/31/2024, R2200079 Exp. Date 12/31/2024, R2200081 Exp. Date 12/31/2024, P2200691 Exp. Date 1/31/2025, P2200692 Exp. Date 1/31/2025, P2200693 Exp. Date 1/31/2025, P2201499 Exp. Date 2/28/2025, P2201498 Exp. Date 2/28/2025, R2200579 Exp. Date 4/30/2025, P2203881 Exp. Date 5/31/2025, P2203441 Exp. Date 5/31/2025, P2203442 Exp. Date 5/31/2025, R2200949 Exp. Date 6/30/2025, R2201094 Exp. Date 6/30/2025, R2201003 Exp. Date 7/31/2025,", "more_code_info": ""}, {"status": "Terminated", "city": "Bellflower", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72361", "recalling_firm": "Pacific Healthcare, Inc dba B&B Pharmacy", "address_1": "10244 Rosecrans Ave", "address_2": "N/A", "postal_code": "90706-2602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA and NJ", "recall_number": "D-0175-2016", "product_description": "PAPA/PGE1/PHENTO (30mg/40mcg/1mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "recall_initiation_date": "20151007", "center_classification_date": "20151110", "termination_date": "20160407", "report_date": "20151118", "code_info": "07022015@3, exp 12/29/2015"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71844", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1822-2015", "product_description": "PHENYLephrine HCl, 40 mg added to 250 mL 0.9% Sodium Chloride Injection USP (160 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX  77478, NDC# 61553-169-50", "product_quantity": "24 bags", "reason_for_recall": "Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).", "recall_initiation_date": "20150128", "center_classification_date": "20150923", "termination_date": "20170127", "report_date": "20150930", "code_info": "Lot #:  14309095S, Exp 02/03/15; 14311008S, Exp 02/05/15"}, {"status": "Terminated", "city": "Glendora", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68299", "recalling_firm": "Oasis Medical Inc", "address_1": "514 S Vermont Ave Bldg 510-528", "address_2": "N/A", "postal_code": "91741-6205", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in US", "recall_number": "D-1347-2014", "product_description": "Oasis TEARS, Lubricant Eye Drops, 10mL/0.3 fl. oz. Bottle, OTC Only. Distributed by: OASIS, OASIS Medical, Inc., Glendora, CA 91741. UPC: 8 54819 00002 3.", "product_quantity": "10,549 Bottles", "reason_for_recall": "Labeling: Missing Label; The label on the immediate bottle is missing.", "recall_initiation_date": "20140514", "center_classification_date": "20140522", "termination_date": "20141217", "report_date": "20140528", "code_info": "Lot #: OTM-07, Expiry: 12/2015."}, {"status": "Ongoing", "city": "Kalamazoo", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81838", "recalling_firm": "Torrent Pharma Inc.", "address_1": "1803 Whites Rd Ste 1", "address_2": "", "postal_code": "49008-2883", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0505-2019", "product_description": "LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS, USP  50 mg/12.5 mg, a) 90-count bottle (NDC: 13668-116-90), b) 1000-count bottle (NDC: 13668-116-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda", "product_quantity": "18,780 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20181220", "center_classification_date": "20190215", "report_date": "20190227", "code_info": "Count, lots, expiry: [90-count bottle] Lot BP02C008, exp 03/2019; [1000-count bottle] Lots BEF7D006, exp 03/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82314", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1044-2019", "product_description": "Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified", "recall_initiation_date": "20190305", "center_classification_date": "20190321", "termination_date": "20201207", "report_date": "20190327", "code_info": "Lots: 20961 Exp. 09/2019; 20477 Exp. 08/2019"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0437-2025", "product_description": "Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 6.4 OZ (181 grams) Box, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-07", "product_quantity": "4,176 boxes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0067, Exp Date: 08/31/2026"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0370-2021", "product_description": "Burro en Primavera, 2 capsules, UPC 638632431055", "product_quantity": "500 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1523-2014", "product_description": "Vitamin B6 Pyridoxine HCL for Injection USP, 100 mg/ml,  Sterile, for IM or Deep SQ Use, Multiple Dose 30 ml vial, manufactured by: CB Inc. for Sunshine Labs, www. sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"country": "United States", "city": "Rockford", "address_1": "4901 Hiawatha Dr", "reason_for_recall": "Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL", "address_2": "", "product_quantity": "936 vials", "code_info": "Lot Number: 7801009; Exp: Apr-2015", "center_classification_date": "20150313", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "DOXOrubicin Hydrochloride Injection, USP, 200 mg/100 mL (2 mg/mL), For IV Use Only, Sterile, ISOTONIC SOLUTION, Caution: Cytotoxic Agent, 100 mL Multi-Dose Vial, Rx Only, Manufactured By: Onco Therapies Limited, Bangalore, 560105, INDIA, Distributed By: Amneal-Agila, LLC, Glasgow, KY, 42141, NDC 53150-317-01.", "report_date": "20150325", "classification": "Class III", "openfda": {}, "recalling_firm": "Mylan Institutional LLC", "recall_number": "D-0412-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "70565", "termination_date": "20160209", "more_code_info": "", "recall_initiation_date": "20150211", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Tonawanda", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89462", "recalling_firm": "CooperSurgical, Inc", "address_1": "825 Wurlitzer Dr", "address_2": "N/A", "postal_code": "14120-3041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0643-2022", "product_description": "PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white rod in a Tyvek polyethylene pouch, Rx Only, Manufactured by Teva Women's Health Inc. a subsidiary of Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 51285-204-01", "product_quantity": "48,645 cartons", "reason_for_recall": "Non-sterility", "recall_initiation_date": "20220204", "center_classification_date": "20220301", "termination_date": "20230206", "report_date": "20220223", "code_info": "Lot # 517001,Exp 1/2024"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0660-2023", "product_description": "Cardioplegia Solution, Induction 8:1 High Potassium, 108 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0102-1.", "product_quantity": "544 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894305, Exp 04/29/2023; 37-896153, Exp 05/06/2023; 37-897073, Exp 05/11/2023; 37-897925, 37-897941, Exp 05/13/2023; 37-899607, 37-899608, Exp 05/20/2023; 37-900320, Exp 05/22/2023"}, {"status": "Terminated", "city": "Olive Branch", "state": "MS", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73332", "recalling_firm": "J. Strickland and Co", "address_1": "10420 Desoto Rd", "address_2": "N/A", "postal_code": "38654-5301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Jamaica and Bahamas", "recall_number": "D-0734-2016", "product_description": "sulfur8 medicated LIGHT FORMULA (sulfur) anti-dandruff hair & scalp conditioner, 2%, packaged in a) 2 OZ (57g) jar (UPC 0 75610 43510 8), and b) 4 OZ (113g) jar (UPC 0 75610 43610 5), 1 dozen jars per case, J. Strickland & Co., PO Box 1637, Olive Branch, MS 38654", "product_quantity": "1170 cases", "reason_for_recall": "Subpotent Drug: failed at the 3 and 6 month stability time points.", "recall_initiation_date": "20160211", "center_classification_date": "20160302", "termination_date": "20161122", "report_date": "20160309", "code_info": "Lot #: 33UF"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["BISACODYL"], "generic_name": ["BISACODYL"], "manufacturer_name": ["GERI-CARE PHARMACEUTICAL CORP"], "product_ndc": ["57896-443"], "product_type": ["HUMAN OTC DRUG"], "route": ["RECTAL"], "substance_name": ["BISACODYL"], "rxcui": ["198509"], "spl_id": ["41d6e645-b654-726f-e063-6394a90a101b"], "spl_set_id": ["a747a57a-028e-70ea-e053-2a95a90ac184"], "package_ndc": ["57896-443-66", "57896-443-12", "57896-443-55", "57896-443-05", "57896-443-01"], "is_original_packager": [true], "upc": ["0357896444051"], "nui": ["N0000009371", "N0000175812", "N0000009871"], "pharm_class_pe": ["Increased Large Intestinal Motility [PE]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "pharm_class_epc": ["Stimulant Laxative [EPC]"], "unii": ["10X0709Y6I"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1312-2022", "product_description": "Bisacodyl Suppositories, Fast Acting Stimulant Laxative, 100 suppositories per box, 10 mg each, Health Star, NDC 57896-443-01.", "product_quantity": "45 boxes", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "Part# 444-01-HST", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0693-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0422-1.", "product_quantity": "747 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893819, Exp 04/28/2023; 37-894702, 37-894710, Exp 04/30/2023; 37-895215, Exp 05/04/2023; 37-897282, Exp 05/12/2023; 37-897921, Exp 05/13/2023; 37-898309, Exp 05/14/2023; 37-899199, Exp 05/19/2023; 37-900058, Exp 05/21/2023"}, {"status": "Ongoing", "city": "Saddle Brook", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82337", "recalling_firm": "Rising Pharmaceuticals, Inc.", "address_1": "250 Pehle Ave Ste 601", "address_2": "N/A", "postal_code": "07663-5832", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.", "recall_number": "D-1053-2019", "product_description": "Valsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by:  Acetris Health, LLC, Saddle Brook, NJ 07663, Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810 --- NDC 52343-123-90", "product_quantity": "37,410 bottles", "reason_for_recall": "CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products", "recall_initiation_date": "20190307", "center_classification_date": "20190321", "report_date": "20190327", "code_info": "471170019A, exp. date 10/31/2019  471180006A, exp. date 03/31/2020  471180007A, exp. date 03/31/2020  471180016A, exp. date 05/31/2020"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "70 vials", "code_info": "Lot #: a) 20130321-E, Exp 6/21/2013; b) 20130215-F, Exp 5/15/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Modified Myers Cocktail Injection, all strengths and all presentations including a) Mod Meyer's Cocktail 37 mL and b) Modified Myers Cocktail 37 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-396-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204200"], "brand_name": ["ADRENALIN"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["ENDO USA, Inc."], "product_ndc": ["42023-159", "42023-168"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["310132", "1490057", "1660014", "1660016"], "spl_id": ["ed8fb63a-8526-4e61-adb4-4da9d3d4f2a0"], "spl_set_id": ["3b7a4364-668d-4eb2-a20c-04adc35aabe4"], "package_ndc": ["42023-159-01", "42023-159-25", "42023-168-01"], "is_original_packager": [true], "upc": ["0342023168016"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1022-2022", "product_description": "Adrenalin (epinephrine injection, USP) 30 mg/30 mL (1mg/mL), 30 mL multiple dose vial, Rx only, MFG: Par Pharma, NDC 42023-168-01", "product_quantity": "58 cartons", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-235-2014", "product_description": "Mic Ultra 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "76 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5553-1"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "87980", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0394-2021", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDC 68968-5553-1) per box (NDC 68968-5553-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.", "product_quantity": "6,689 boxes", "reason_for_recall": "Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.", "recall_initiation_date": "20210520", "center_classification_date": "20210524", "report_date": "20210602", "code_info": "Lot: 88530 Exp. 10/2021"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82832", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "IL, MI, MN, PA, TN, TX. Two (2) US government  and one (1) Veterans Affairs accounts. No foreign accounts.", "recall_number": "D-1285-2019", "product_description": "Losartan Potassium Tablets USP 100 mg 90 count bottle NDC 60429-318-90 Rx only GSMS Incorporated", "product_quantity": "138,213 HDPE Bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer", "recall_initiation_date": "20190501", "center_classification_date": "20190519", "termination_date": "20200225", "report_date": "20190529", "code_info": "GS014045,exp 06/2019, GS014305 exp 06/2019, GS014044 exp 0/2019,   GS016535 exp 01/2020, GS016524 exp 01/2020, GS017384 exp 02/2020, GS017385 exp 01/2020, GS017539 exp 01/2020,   GS017540 exp 01/2020, GS017543 exp 01/2020, GS017542 exp 01/2020  GS017984 exp 02/2020, GS017985 exp 02/2020, GS017986 exp 02/2020, GS018263 exp 02/2020, GS018264 exp 02/2020, GS018265 exp 02/2020"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1110-2020", "product_description": "Asma Stopper, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-  0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88340", "recalling_firm": "People's Custom Rx and Clinical Care, LLC", "address_1": "785 E Brookhaven Cir", "address_2": "N/A", "postal_code": "38117-4501", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS, TN", "recall_number": "D-0718-2021", "product_description": "C-PROGESTERONE OIL 100 MG/ML, 10 mL vials, Compound, People's Custom Rx, Compounded, Rx only, People's Custom Rx, 785 E Brookhaven Cir, Memphis, TN  38117", "product_quantity": "14 vials", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20210511", "center_classification_date": "20210809", "termination_date": "20240820", "report_date": "20210818", "code_info": "Lot: 11649 BUD: 07/07/2021"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87514", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA only", "recall_number": "D-0307-2021", "product_description": "Epinephrine/Lidocaine HCl, Sterile Ophthalmic Solution for Injection, 0.8 mL per syringe, Single Use Syringe, 0.025%/0.75%, Rx only, Edge Pharma LLC 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0863-01", "product_quantity": "60 syringes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20201222", "center_classification_date": "20210318", "termination_date": "20210610", "report_date": "20210324", "code_info": "Lot #: 10-2020-13@8, exp. date 12/03/2020"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1233-2022", "product_description": "Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a) 4 mL-vial, b)10mL-vial, Room temperature, Tailor Made Compounding", "product_quantity": "106 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: a)10142123A2, Exp 4/12/2022, 02042202A1, Exp 8/3/2022; b) 10142121A2, Exp 4/12/2022; 10202105A1, Exp 4/18/2022; 11102102A1, Exp 4/30/2022; 02042202A1, Exp 8/3/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76407", "recalling_firm": "Cherry Hill Sales Co.", "address_1": "1115 Eden Way N", "address_2": "N/A", "postal_code": "23320-2751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Michigan, Illinois, New York, Florida, Pennsylvania .", "recall_number": "D-0484-2017", "product_description": "MakeSense PHARMA FIRST AID CREAM Lidocaine HCL 0.5%, Phenol 0.5%, 1 oz.. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-210-28", "product_quantity": "7,200 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170127", "center_classification_date": "20170218", "termination_date": "20170419", "report_date": "20170301", "code_info": "Lot # 103814; Exp. 09/17  Lot # 105306; Exp. 04/18   NDC 69020-210-28  UPC 85718005139"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0379143    0379249", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PACLITAXEL 6MG/ML INJECTABLE\t500 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1591-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73715", "recalling_firm": "Amerisource Health Services", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0823-2016", "product_description": "Fenofibrate Capsules (Micronized), 200 mg , 30-count Unit Dose Blister Packs per carton, Rx Only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 Carton of 30:NDC 68084-835-32, Individual Dose: NDC 68084-835-33.", "product_quantity": "5,034 cartons (151,020 capsules)", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20160331", "center_classification_date": "20160414", "termination_date": "20170111", "report_date": "20160420", "code_info": "Lot #142548; Exp. 05/16  Lot #145036; Exp. 10/16  Lot #151170; Exp. 03/17   Lot #152978; Exp. 09/17   Lot #155080; Exp. 01/18.", "more_code_info": ""}, {"country": "United States", "city": "Lexington", "address_1": "300 Shire Way", "reason_for_recall": "Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing", "address_2": "", "product_quantity": "13,897", "code_info": "06628461, exp 8/31/2020  06661658, 07110136, 7164106, 07761970 exp 10/31/2020 07630717, 08689119, exp 12/31/2020   07769458, exp 4/30/2021  07983643, 08003758, exp 6/30/2021  08214790, exp 8/31/2020  NY17002DA, NY17002DB, exp 6/30/2020", "center_classification_date": "20191001", "distribution_pattern": "Product was distributed throughout the United States.", "state": "MA", "product_description": "Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0203-02", "report_date": "20191002", "classification": "Class I", "openfda": {}, "recalling_firm": "Shire Human Genetic Therapies, Inc.", "recall_number": "D-0036-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "83792", "termination_date": "20210323", "more_code_info": "", "recall_initiation_date": "20190912", "postal_code": "02421-2101", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "25 units", "code_info": "Rx #'s:  0402838    0366311      0393844      0405862    0369802    0361586    0362348      0367636      0354323      0361586      0376846    0395405    0401667    0404458    0356814      0372189", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DAPIPRAZOLE OPHTHALMIC 0.5% SOLUTION 10 ML; DAPIPRAZOLE, LYOPHILIZED, OPHTHALMIC KIT 0.5% POWDER 1 KIT, 10 KIT, 2 KIT, 3 KIT, 4 KIT, 6 KIT (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1495-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0397-2020", "product_description": "Ocusoft Goniosoft Hypromellose 2.5% Opthalmic Demulcent Solution, 15 mL, Manufactured for: Ocusoft, Inc., Richmond, TX 77406-0429, NDC 54799-503-15", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "16260 9/19  17303 10/20  18032 2/21  18235 9/21  18285 11/21  19021 1/22"}, {"status": "Ongoing", "city": "Siddipet (District)", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA217166"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-305", "31722-306", "31722-307"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["23a5daec-e083-eec0-e063-6394a90a2411"], "spl_set_id": ["478aff0b-29fd-43b2-a701-5236b8f8e3df"], "package_ndc": ["31722-305-25", "31722-305-10", "31722-306-25", "31722-307-25", "31722-307-02"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "97711", "recalling_firm": "Aspiro Pharma Limited", "address_1": "Survey No. 321, Biotech Park, Phase Iii", "address_2": "Karkapatla Village, Markook (Mandal)", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0036-2026", "product_description": "Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).", "product_quantity": "", "reason_for_recall": "Presence of Particulate Matter: Particulate matter identified as glass", "recall_initiation_date": "20251001", "center_classification_date": "20251021", "report_date": "20251029", "code_info": "Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1109-2020", "product_description": "Age Stop Ex, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-  0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0201-2015", "product_description": "LIDOCAINE HCL (REPKG-STERILE), 4%, solution for irrigation, 5 mL, 6 mL, and 7 mL plastic dropper bottle, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "49/5 mL bottles; 40/6 mL bottles; 30/7 ml bottles", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140815@12, discard date: 2/16/2015"}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95853", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0162-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "76,968 bottles", "reason_for_recall": "CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot #  230077C, exp. date 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Conway", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82969", "recalling_firm": "Synthetopes Inc", "address_1": "216 Earnhardt St", "address_2": "N/A", "postal_code": "29526-8287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1399-2019", "product_description": "Pentreotide (10 uGm), Not for Direct Injection, Synthetopes, Inc.", "product_quantity": "20 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20190528", "center_classification_date": "20190620", "termination_date": "20201015", "report_date": "20190619", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-845-2015", "product_description": "Piroxicam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2900 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0489-2020", "product_description": "Clear Eyes Redness Relief (Handy Pocket Pal), Product Size: 0.2 FL. Oz., UPC#: 6-78112-15418-7", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 16192, Exp 7/19; 16203, Exp 7/19; 16242, Exp 9/19; 16280, Exp 10/19; 16285, Exp 10/19; 16300, Exp 11/19; 16336, Exp 12/19; 17002, Exp 1/20; 17012, Exp 1/20; 17051, Exp 2/20; 17130, Exp 04/20; 17147, Exp 05/20"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0105-2023", "product_description": "QuadMix Super 001 (PGE1/Papaverine HCl/Phentolamine Mesylate/Atropine) 40mcg/30mg/2mg/0.4mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "56 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11162022@7, Exp 12/31/2022", "more_code_info": ""}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "1 vial (10 mL)", "code_info": "ALL Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "BiMix Customs Injectable  Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-294-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0749-2023", "product_description": "vasopressin 50 units added to 0.9% sodium chloride 50 mL*, 1 unit/mL*, 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-9002-1.", "product_quantity": "4259 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883209, 37-883211, 37-883212, 37-883214, 37-883215, Exp 04/30/2023; 37-883776, Exp 05/02/2023; 37-884451, Exp 05/04/2023; 37-884805, 37-884806, 37-884808, 37-884810, 37-884811, Exp 05/07/2023; 37-886498, 37-886506, 37-886507, 37-886509, 37-886511, 37-886512, Exp 05/14/2023; 37-887319, 37-887321, Exp 05/16/2023; 37-889572, 37-889574, Exp 05/24/2023; 37-890881, 37-890883, 37-890884, 37-890887, Exp 05/30/2023; 37-892003, 37-892004, 37-892006, Exp 06/05/2023; 37-893157, Exp 06/08/2023; 37-893460, 37-893461, 37-893463, Exp 06/11/2023; 37-894619, 37-894648, 37-894650, Exp 06/14/2023; 37-895213, 37-895216, 37-895219, 37-895223, 37-895225, Exp 06/18/2023; 37-896813, Exp 06/22/2023; 37-897069, 37-897074, Exp 06/25/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-782-2015", "product_description": "Methimazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0181-2022", "product_description": "TESTOSTERONE CYPIONATE 20MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "7 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T0507152021:64 BUD: 01/11/2022; T0507232021:35 BUD: 01/19/2022; T0507292021:15 BUD: 01/25/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0028-2020", "product_description": "C-PAPAV/PHENTOL/PGE1 30MG/1MG/50MCG/ML, 5 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 062419B, BUD 08/08/19"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-031-2013", "product_description": "Premier Value Fiber Plus Calcium Supplement Capsules, 120 capsules per bottle, Distributed by: Chain Drug Consortium, LLC, Boca Raton, FL, UPC 8-40986-01987-6", "product_quantity": "96 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 15087, Exp 08/15"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87833", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Distributed to two physician consignees located in FL.", "recall_number": "D-0385-2021", "product_description": "Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1", "product_quantity": "147 bottles (14,700 extended release tablets)", "reason_for_recall": "CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.", "recall_initiation_date": "20210428", "center_classification_date": "20210516", "report_date": "20210526", "code_info": "Lot Codes: C2520W,Exp.12/31/2021; E0620F, Exp. 12/31/2021; G2020M, Exp. 4/30/2022; G2720A, Exp. 4/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["ENBRACE HR"], "generic_name": ["LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, AND PHOSPHATIDYL SERINE"], "manufacturer_name": ["Jaymac Pharma"], "product_ndc": ["64661-650"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM", "1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM", "BETAINE", "COBAMAMIDE", "COCARBOXYLASE", "FERROUS CYSTEINE GLYCINATE", "FLAVIN ADENINE DINUCLEOTIDE", "FOLIC ACID", "LEUCOVORIN", "LEVOMEFOLATE MAGNESIUM", "MAGNESIUM ASCORBATE", "MAGNESIUM L-THREONATE", "NADH", "PHOSPHATIDYL SERINE", "PYRIDOXAL PHOSPHATE ANHYDROUS", "ZINC ASCORBATE"], "spl_id": ["136a126c-9b1e-4258-9785-cc6959ef6a0f"], "spl_set_id": ["6f14fa40-97ab-4ec5-b66b-793d6d1abac9"], "package_ndc": ["64661-650-30"], "is_original_packager": [true], "upc": ["0364661650302"], "nui": ["N0000175804", "N0000175805", "N0000178369", "M0008658"], "pharm_class_moa": ["Methylating Activity [MoA]"], "pharm_class_epc": ["Methylating Agent [EPC]", "Folate Analog [EPC]"], "pharm_class_cs": ["Folic Acid [CS]"], "unii": ["6WJM73T46K", "9ABD9DRK7B", "3SCV180C9W", "F0R1QK73KB", "Q57971654Y", "8B4OP7RK5N", "ZC44YTI8KK", "935E97BOY8", "Q573I9DVLP", "1VZZ62R081", "0N1G678593", "1Y26ZZ0OTM", "4J24DQ0916", "394XK0IH40", "F06SGE49M6", "9TI35313XW"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0496-2021", "product_description": "Enbrace HR 30 ct. Softgels Enhanced Prenatal Vitamin Supplement Rx NDC 64661-650-30 Manufactured for: JAYMAC Pharmaceuticals, LLC, Sunset, LA 70584", "product_quantity": "11 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "86 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@22, 5/31/2015; 04072015@66, 7/6/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 25 mg/ml + Baclofen 100 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1591-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1269-2022", "product_description": "del Nido Cardioplegia Solution 1000 mL (1000 mL) Single-Dose Container IV bag, 4 x 1 IV Bag per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-984-10", "product_quantity": "1765 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: NC2031A, Exp. 7/7/2022; NC2033A, Exp. 7/12/2022; NC2034A, Exp. 7/18/2022; NC2035A, Exp. 7/19/2022"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1050-2022", "product_description": "Xylocaine - MPF (lidocaine HCl and epinephrine injection, USP), 1%, 300 mg/30 mL, single dose vial, 5-count box, Rx only, MFG: App Pharmaceuticals LLC, NDC 63323-0487-31", "product_quantity": "1 vial", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0037-2018", "product_description": "Oxytocin 15 units added to 250 mL Lactated Ringer's Injection USP in 250 mL bag, Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130, Sugar Land, TX 77478, NDC# 71019-239-01", "product_quantity": "2232 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1458-2022", "product_description": "HYLANDS 4KIDS COLD N MUCUS RELIEF 4 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 999246", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1459-2020", "product_description": "BC Hemp Co., Full Spectrum Hemp Extract, CBD Oil, Spearmint, 500mg CBD, 1 FL. OZ (30 ML) bottles, Distributed by: B.C. Hemp Co., LLC, P.O. Box 156, Eau Claire, MI 49111", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003315", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0070-2020", "product_description": "Lidocaine HCl 30 mg/mL/Hyaluronidase 15 Units/mL (PF) 5 mL Fill in a 6 mL Single Dose Syringe,  Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678368", "product_quantity": "2615 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Westbury", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69243", "recalling_firm": "Gyma Laboratories Of Amer,Inc", "address_1": "135 Cantiague Rock Rd", "address_2": "N/A", "postal_code": "11590-2826", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0024-2015", "product_description": "Clonidine HCL, 97 Kg, Rx Only, S.I.M.S. , Chemical Product for Medicines Preparation, Made in Italy, NDC 012660-0002", "product_quantity": "97 Kg", "reason_for_recall": "cGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued by The Italian Medicines Agency due to lack of good manufacturing practices.", "recall_initiation_date": "20140709", "center_classification_date": "20141010", "termination_date": "20180604", "report_date": "20141022", "code_info": "Lot Numbers: 167219, 163367, 167220, 167221, Exp 03/2017"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-937-2015", "product_description": "Tramadol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "116900 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "11 vials", "code_info": "a) Lot #: 20180129@18, BUD 4/14/2018  b) Lot #: 20171127@6, 20180207@12, 20180108@16, BUD 04/14/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Methionine15mg/Inositol 50mg/Choline 100mg, packaged in a) 5mL and b) 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0641-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0825-2022", "product_description": "Ultratest, Testosterone Cypionate 160 mg/mL, Testosterone Propionate 40 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0058-10.", "product_quantity": "1276 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E48020 BUD: 5/20/2022 and G47006 BUD: 7/6/2022", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as one of the following drugs:  ATORVASTATIN CALCIUM, Tablet, 80 mg, NDC 00378212277, Pedigree: W003213, EXP: 6/14/2014;  PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011010, Pedigree: AD65317_1, EXP: 5/24/2014.", "address_2": "", "product_quantity": "200 Capsules", "code_info": "MYCOPHENOLATE MOFETIL, Capsule, 250 mg has the following codes:   Pedigree: W003215, EXP: 6/14/2014;  Pedigree: AD65457_7, EXP: 5/24/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781206701.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1005-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waynesboro", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81811", "recalling_firm": "Duren Health Mart Pharmacy", "address_1": "215 Dexter L Woods Memorial Blvd", "address_2": "N/A", "postal_code": "38485-2416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TN only", "recall_number": "D-0419-2019", "product_description": "Promethazine Gel 50 mg/mL, 1cc to 10cc per prescription, Rx  only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN38485, NDC 00002-1901-03", "product_quantity": "876 cc", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20181217", "center_classification_date": "20190128", "termination_date": "20220119", "report_date": "20190206", "code_info": "N/A"}, {"status": "Terminated", "city": "Smyrna", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021505"], "brand_name": ["KEPPRA"], "generic_name": ["LEVETIRACETAM"], "manufacturer_name": ["UCB, Inc."], "product_ndc": ["50474-001", "50474-594", "50474-595", "50474-596", "50474-597"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["261335", "261336", "284391", "311288", "311289", "311290", "387003", "403884", "404595", "630807"], "spl_id": ["38655400-cd09-4f8e-e063-6294a90a7afd"], "spl_set_id": ["3ca9df05-a506-4ec8-a4fe-320f1219ab21"], "package_ndc": ["50474-594-40", "50474-595-40", "50474-596-40", "50474-597-66", "50474-001-48"], "is_original_packager": [true], "upc": ["0350474595404"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "83368", "recalling_firm": "Ucb, Inc", "address_1": "1950 Lake Park Dr Se", "address_2": "N/A", "postal_code": "30080-7648", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "TN", "recall_number": "D-1838-2019", "product_description": "Keppra (levetiracetam) 1000 mg tablets, 60 tablets per bottle,  Rx only, Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-597-66.", "product_quantity": "2088 bottles", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20190718", "center_classification_date": "20190821", "termination_date": "20200124", "report_date": "20190731", "code_info": "Lot: 908946 Exp. 02/2022"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0616-2023", "product_description": "Ceftriaxone for Injection, USP 250 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-094-02", "product_quantity": "66,125 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0444-2021", "product_description": "BENZEFOAM EMOLLIENT FOAM BENZOYL PEROXIDE 5.3% 100GM TOP EMOL NDC 187-0194--10; OTC; FOAMS", "product_quantity": "2 carton", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"country": "United States", "city": "Huntsville", "address_1": "150 Vintage Dr NE", "reason_for_recall": "Superpotent Drug: above specification for the assay.", "address_2": "", "product_quantity": "109,620 bottles", "code_info": "Lot #:  0000004961, Exp. 05/17; 0000005197, 0000005198, 0000005199, Exp.  07/17; 0000005201, 0000005202, 0000005203, 0000005204, Exp. 09/17; 0000005200, 0000007998, 0000007999, 0000007022, Exp. 12/17; 0000009176, Exp. 04/18; 0000012281, 0000012282, Exp. 12/18", "center_classification_date": "20170523", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "state": "AL", "product_description": "HYDROCORTISONE LOTION, USP, 2.5%, 2 FL OZ (59 mL) bottle, Rx only, Manufactured for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL  35811, NDC 0603-7785-52.", "report_date": "20170531", "classification": "Class III", "openfda": {}, "recalling_firm": "Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals", "recall_number": "D-0859-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77210", "termination_date": "20180502", "more_code_info": "", "recall_initiation_date": "20170508", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85306", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Bulk product was distributed to one re-packager in California.", "recall_number": "D-1100-2020", "product_description": "LOSARTAN POTASSIUM TABLETS, USP 25 mg, Bulk, Rx only, For Further Manufacturing, Packing or Repackaging only, Manufactured by: Arrow Pharma (Malta) Ltd., Birzebbugia Malta NDC 0591-3745-00", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.", "recall_initiation_date": "20200325", "center_classification_date": "20200407", "report_date": "20200415", "code_info": "Lots 1207344A, exp. date 06/2020;   1207343A, 1207342A, exp. date 07/2020"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0136-2023", "product_description": "Ciprofloxacin Ophthalmic Solution, USP 0.3% (Ciprofloxacin HCl), 2.5mL per bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  NDC: 17478-714-25", "product_quantity": "1,584 bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot:  Lot 1E22A, EXP 10/31/2022"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "5 Bags", "code_info": "All product compounded between May 14, 2015 and May 27, 2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "TPN 3:1, 1750 mL Bags, Qty: 5, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Water for Inj; Electrolytes Famotidine, KCL, K Phos, Na Acetate, MgSO4, NaCl; Vitamins, trace elements and medications Multitrace-4, Multi Vitamin, Vitamin K, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1161-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tamarac", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82754", "recalling_firm": "Unipharma, Llc.", "address_1": "10200 NW 67th St", "address_2": "", "postal_code": "33321-6404", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Venezuela", "recall_number": "D-1300-2019", "product_description": "CVS Health Children's Allergy Relief Liquid Medication Diphenhydramine HCl 12.5 mg/5 mL Oral Solution Antihistamine Mixed Berry Flavor 20 Single-Use 0.17 fl. oz. (5 mL), Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895,  NDC 69842-261-01, UPC 050428597156", "product_quantity": "27840 cartons", "reason_for_recall": "CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.", "recall_initiation_date": "20190502", "center_classification_date": "20190523", "termination_date": "20201125", "report_date": "20190522", "code_info": "Lots: 80058; 80059 Exp. 11/30/20", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: glyBURIDE, Tablet, 1.25 mg may have potentially been mislabeled as one of the following drugs:  CYPROHEPTADINE HCL, Tablet, 4 mg, NDC 60258085001, Pedigree: W003676, EXP: 6/25/2014;  AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: AD21790_1, EXP: 5/1/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "glyBURIDE, Tablet, 1.25 mg has the following codes:   Pedigree: W003677, EXP: 2/28/2014;  Pedigree: AD21790_10, EXP: 2/28/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "glyBURIDE, Tablet, 1.25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834201.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-853-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0239-2016", "product_description": "Betamethasone Combo PF 2 mL (6 mg/mL) 10 mL  Multi-Dose Vial, For IM & Regional Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3018-02", "product_quantity": "5,514 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Numbers: 20150206@41 BUD: 11/28/2015; 20151603@58 BUD: 9/12/2015; 20152007@43 BUD: 1/16/2016; 20152104@41 BUD: 10/18/2015"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "10 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #s: 10152013@20", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "SODIUM HYDROXIDE (BAC.STATIC) 10% SOLUTION, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-460-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2000 mL in Vials", "code_info": "a) Lot #: 160125-14, BUD: 07/23/16;  Lot #: 160315-12, BUD: 09/11/16.  b) Lot #: 160125-14, BUD: 07/23/16;  Lot #: 160315-12, BUD: 09/11/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "TRYPTOPHAN 10MG/ML (PF), In a) 10ML Vials and b) 50ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1249-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68191", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States: TX, IL, MD, IN", "recall_number": "D-1568-2014", "product_description": "Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL pre-filled syringe, Rx Only.  Pharmakon Pharmaceuticals, Inc., 14450 Getz Road, Noblesville, IN.  NDC: 45183-0105-78.", "product_quantity": "5 Syringes", "reason_for_recall": "Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.", "recall_initiation_date": "20140421", "center_classification_date": "20140826", "termination_date": "20141203", "report_date": "20140903", "code_info": "Lot #: E0333282R; Exp: 7/13/2014"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73811", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-0867-2016", "product_description": "OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-04", "product_quantity": "40,280 vials", "reason_for_recall": "Failed Impuities/Degradation Specifications", "recall_initiation_date": "20160504", "center_classification_date": "20160524", "termination_date": "20170123", "report_date": "20160601", "code_info": "Lot # 6108831; Exp. 07/16"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76432", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0517-2017", "product_description": "Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56", "product_quantity": "7,628 HDPE bottles (228,840 tablets)", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20170207", "center_classification_date": "20170310", "termination_date": "20180216", "report_date": "20170322", "code_info": "Lot 30227056A; Exp. 03/17"}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0012-2020", "product_description": "C-HYDROXOCOBALAMIN 5 MG/ML INJECTION SOLUTION, 1 mL syringe, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "30 syringe", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 062619E, BUD 08/10/19"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0742-2018", "product_description": "Cosentyx 150 mg/mL PFS 300 mg Dose NDC 00078-0639-98, 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1039-2023", "product_description": "CARDIOPLEGIA SOLUTION, 36 mEq K, Maintenance 8:1, low Potassium / low dextrose, IV Bag, total volume = 500 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0108-1", "product_quantity": "84 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254906, Exp. 7/22/2023."}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["415fe396-0d2b-40a9-e063-6294a90a8462"], "spl_set_id": ["85791e13-4103-19fe-e053-2991aa0a647f"], "package_ndc": ["54365-400-38"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "87715", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0373-2021", "product_description": "BD ChloraPrep Hi-Lite Orange 26 mL Applicator (2% w/v chlorhexidine gluconate (CHG) and 70% v/v Isopropyl alcohol (IPA)) Sterile Solution, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co, NDC 54365-400-38", "product_quantity": "707,050 eaches", "reason_for_recall": "Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.", "recall_initiation_date": "20210420", "center_classification_date": "20210510", "termination_date": "20230621", "report_date": "20210519", "code_info": "Lot #: 0108186, Exp. 4/30/2023; 0327867, 0327868, 0328213, 0338656, 0339071, 0328947, 0328949, 0329475, 0329477, 0330457, 0330955, 0330606   0333826, 0333852, 0333855, 0334119, 0335787, 0335792, 0335029, 0336506   0336972, 0336051, 0337245, 0337025, 0338653, 0338542, 0338852, 0339892   0339457, Exp. 11/30/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77647", "recalling_firm": "ImprimisRx CA, Inc., dba ImprimisRx", "address_1": "9257 Research Dr", "address_2": "N/A", "postal_code": "92618-4286", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1130-2017", "product_description": "Curcumin Emulsion 10mg/ml Injection, Sterile 10 mL Multiple Dose Vial, For Slow IV Administration, Compounded for a licensed professional or patient use by ImprimisRx, Irvine, CA", "product_quantity": "2608 vials", "reason_for_recall": "Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier", "recall_initiation_date": "20170623", "center_classification_date": "20170907", "termination_date": "20190114", "report_date": "20170913", "code_info": "03212017@21B             Exp:6/19/2017;  03232017@19B Exp:6/21/2017;  03292017@27B Exp:6/27/2017;  03292017@9B Exp:6/27/2017;  04042017@21B Exp:7/3/2017;  04122017@22B Exp:7/11/2017;  04132017@14B Exp:7/12/2017;  04192017@37B Exp:7/18/2017;  04192017@17B Exp:7/18/2017;  04242017@18B Exp:7/23/2017"}, {"status": "Ongoing", "city": "Athens", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95826", "recalling_firm": "Midlab Incorporated", "address_1": "140 Private Brand Way", "address_2": "", "postal_code": "37303-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0091-2025", "product_description": "Genuine Joe Antibacterial Lotion Soap , Chloroxylenol 0.1%, 1 GALLON (3.78L), Manufactured in the U.S.A. for S.P. Richards Co., Atlanta, GA 30339", "product_quantity": "", "reason_for_recall": "cGMP Deviations: Out of specification results for micro in hand soap products.", "recall_initiation_date": "20241106", "center_classification_date": "20241202", "report_date": "20241211", "code_info": "Lot 0711241", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; MESALAMINE CR, Capsule, 250 mg may be potentially mislabeled as    ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD52378_1, EXP: 5/17/2014.", "address_2": "", "product_quantity": "240 Capsules", "code_info": "MESALAMINE CR, Capsule, 250 mg has the following code    Pedigree: AD52412_1, EXP: 5/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MESALAMINE CR Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 54092018981", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-613-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0209-2019", "product_description": "Trimix T105 PGE/Phentolamine/Papaverine 10 mcg/30 mg/1 mg Injectable Pharm D Solutions, Houston, Texas --- NDC 69699-1351-05", "product_quantity": "40 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04262018:08 Discard by: 10/22/2018; 07242018:81 Discard by: 1/20/2019"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0061-2022", "product_description": "METHYLCOBALAMIN 5000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}]